KIF18A as a potential biomarker to distinguish different breast cancer subtypes based on receptor status

Author:

Berkel CaglarORCID

Publisher

Springer Science and Business Media LLC

Reference48 articles.

1. Alfarsi, L. H., Elansari, R., Toss, M. S., Diez-Rodriguez, M., Nolan, C. C., Ellis, I. O., Rakha, E. A., & Green, A. R. (2019). Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer. Breast Cancer Research and Treatment, 173(1), 93–102. https://doi.org/10.1007/s10549-018-4978-5. Epub 2018 Oct 10. PMID: 30306428.

2. Belete, A. M., Aynalem, Y. A., Gemeda, B. N., Demelew, T. M., & Shiferaw, W. S. (2022). The effect of estrogen receptor status on survival in breast cancer patients in Ethiopia. Retrospective Cohort Study. Breast Cancer (Dove Med Press), 14, 153–161. https://doi.org/10.2147/BCTT.S365295.

3. Berkel, C. (2023). Estrogen receptor- and progesterone receptor-positive breast tumors have higher mRNA levels of NR3C1 and ZBTB16, with implications in prognosis for luminal A subtype. Human Cell. https://doi.org/10.1007/s13577-023-01014-1. Epub ahead of print. PMID: 37999919.

4. Berkel, C., & Cacan, E. (2021). Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer. Biochemical and Biophysical Research Communications, 17(570), 74–81. https://doi.org/10.1016/j.bbrc.2021.07.004. Epub 2021 Jul 14. PMID: 34273621.

5. Berkel, C., & Cacan, E. (2023a). Lower expression of NINJ1 (Ninjurin 1), a mediator of plasma membrane rupture, is associated with advanced disease and worse prognosis in serous ovarian cancer. Immunologic Research, 71(1), 15–28. https://doi.org/10.1007/s12026-022-09323-7. Epub 2022 Oct 3. PMID: 36184655.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3